Don’t miss the latest developments in business and finance.

Dr Reddy's Laboratories launches Nitroglycerin sublingual tablets in U.S. market

Image
Capital Market
Last Updated : Aug 30 2016 | 12:03 AM IST

On 26 August 2016

Dr Reddy's Laboratories has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and 0.6 mg, a therapeutic equivalent generic version of Nitrostat sublingual tablets in the U.S. market on 26 August 2016, having been approved by the United States Food and Drug Administration.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Aug 29 2016 | 1:29 PM IST

Next Story